Johan L. Severens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Johan L. Severens has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
A. L. M. Verbeek
Department of Medical Informatics, Epidemiology and Statistics, University of Nijmegen, the Netherlands
2 shared publicationsA L Verbeek
1 shared publicationAndré L.M Verbeek
Department of Epidemiology, University of Nijmegen, the Netherlands
1 shared publicationAnne M. Kuijpers-Jagtman
Cleft Palate Center, University Hospital Nijmegen, the Netherlands
1 shared publicationBirte Prahl-Andersen
Cleft Palate Center, Vrije Universiteit, Amsterdam, the Netherlands
1 shared publicationCharlotte Prahl
Cleft Palate Center, University Hospital Nijmegen, the Netherlands
1 shared publication
Latest Publications
- 1 December 2001
- Vol. 54 (12)
Efficient diagnostic test sequence: applications of the probability-modifying plot.
- 1 December 2001
- Vol. 54 (12)
Efficient diagnostic test sequence: applications of the probability-modifying plot.
- 1 December 2001
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 54 (12) , 1228-1237
Efficient diagnostic test sequence Applications of the probability-modifying plot
- 1 December 2001
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 54 (12) , 1228-1237
Efficient diagnostic test sequence Applications of the probability-modifying plot
- 1 July 2000
- Published by Elsevier in Social Science & Medicine
- Vol. 51 (2) , 243-249
Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands
- 1 July 2000
- Published by Elsevier in Social Science & Medicine
- Vol. 51 (2) , 243-249
Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands
- 1 January 1999
- Published by Georg Thieme Verlag KG in Methods of Information in Medicine
- Vol. 38 (01) , 50-55
Optimizing Diagnostic Test Sequences: The Probability Modifying Plot
The problem of deciding the optimal sequence of diagnostic tests can be structured in decision trees, but unmanageable bushy decision trees result when the sequence of two or more tests is investigated. Most modelling techniques include tests on the basis of gain in certainty. The aim of this study was to explore a model for optimizing the sequence of diagnostic tests based on efficiency criteria. The probability modifying plot shows, when in a specific test sequence further testing is redundant and which costs are involved. In this way different sequences can be compared. The model is illustrated with data on urinary tract infection. The sequence of diagnostic tests was optimized on the basis of efficiency, which was either defined as the test sequence with the least number of tests or the least total cost for testing. Further research on the model is needed to handle current limitations.
- 1 January 1999
- Published by Georg Thieme Verlag KG in Methods of Information in Medicine
- Vol. 38 (01) , 50-55
Optimizing Diagnostic Test Sequences: The Probability Modifying Plot
The problem of deciding the optimal sequence of diagnostic tests can be structured in decision trees, but unmanageable bushy decision trees result when the sequence of two or more tests is investigated. Most modelling techniques include tests on the basis of gain in certainty. The aim of this study was to explore a model for optimizing the sequence of diagnostic tests based on efficiency criteria. The probability modifying plot shows, when in a specific test sequence further testing is redundant and which costs are involved. In this way different sequences can be compared. The model is illustrated with data on urinary tract infection. The sequence of diagnostic tests was optimized on the basis of efficiency, which was either defined as the test sequence with the least number of tests or the least total cost for testing. Further research on the model is needed to handle current limitations.
- 1 September 1998
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 12 (9) , 919-923
Estimating the cost of lost productivity in dyspepsia
Background: In the field of gastrointestinal disease, productivity costs are highly relevant because work loss is substantial in dyspeptic patients. Productivity costs are normally calculated by multiplying days absent valued by gross earnings. This, however, might lead to an overestimation.Aim: To use a conservative approach to calculating productivity costs, taking absence compensating mechanisms into account.Methods: Patients who visited their general practitioner for the first time with dyspeptic complaints and patients who were known to have persistent dyspeptic complaints were enrolled in two studies. In total, 136 patients completed a questionnaire about their employment situation, absence from work and absence compensating mechanisms.Results: Sixty‐six of the respondents had a paid job, of which 25 (38%) reported absence from work during the previous 4 weeks (average 3.0 days, 1.9 days related to dyspeptic complaints). More than 50% of the employed respondents answered that absence could be compensated for by colleagues, and only in 8% of the cases was absence compensated for by overtime. Using our conservative approach, only one‐quarter of the productivity costs remained, compared to the current approach of valuing each day absent as a loss of productivity.Conclusions: We suggest using both the current and the conservative approaches, analogous to the principles of sensitivity analysis, to avoid overestimation of productivity costs.
- 1 September 1998
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 12 (9) , 919-923
Estimating the cost of lost productivity in dyspepsia
Background: In the field of gastrointestinal disease, productivity costs are highly relevant because work loss is substantial in dyspeptic patients. Productivity costs are normally calculated by multiplying days absent valued by gross earnings. This, however, might lead to an overestimation.Aim: To use a conservative approach to calculating productivity costs, taking absence compensating mechanisms into account.Methods: Patients who visited their general practitioner for the first time with dyspeptic complaints and patients who were known to have persistent dyspeptic complaints were enrolled in two studies. In total, 136 patients completed a questionnaire about their employment situation, absence from work and absence compensating mechanisms.Results: Sixty‐six of the respondents had a paid job, of which 25 (38%) reported absence from work during the previous 4 weeks (average 3.0 days, 1.9 days related to dyspeptic complaints). More than 50% of the employed respondents answered that absence could be compensated for by colleagues, and only in 8% of the cases was absence compensated for by overtime. Using our conservative approach, only one‐quarter of the productivity costs remained, compared to the current approach of valuing each day absent as a loss of productivity.Conclusions: We suggest using both the current and the conservative approaches, analogous to the principles of sensitivity analysis, to avoid overestimation of productivity costs.
- 1 May 1998
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 35 (3) , 222-226
Short-term Cost-effectiveness Analysis of Presurgical Orthopedic Treatment in Children with Complete Unilateral Cleft Lip and Palate
Objective: The aim of this article was to investigate cost-effectiveness in cleft palate treatment using cost-effectiveness of presurgical orthopedic treatment (PSOT) as an example. Design: A three-center randomized clinical trial compared PSOT with non-PSOT for children with unilateral cleft lip and palate (UCLP, n=52). Patients: The inclusion criteria for the trial were: complete UCLP, no other malformations, born at term, both parents Caucasian, trial entrance preferably within 2 weeks after birth, and informed consent by the parents. Interventions: PSOT was performed by means of a passive plate according to Hotz and Gnoinski. Main Outcome Measure: The short-term cost-effectiveness of PSOT was based on the time taken for the surgical lip closure procedure. Medical and nonmedical costs until surgical lip closure at 18 weeks of age were analyzed. Results: The durations of the surgical lip closure procedures did not differ significantly (57.2 minutes for PSOT and 56.4 minutes for non-PSOT). The mean medical cost for PSOT treatment was US$852. The non-PSOT treatment group had a significantly different mean medical cost (US$304). Mean travel costs and indirect nonmedical costs were US$128 and US$231 for PSOT and US$79 and US$130 for non-PSOT, respectively. Conclusions: The combination of a clinical trial and an economic evaluation makes it possible to relate effects to costs involved in treatment alternatives. Longer-term costs and effects will be incorporated into an extended cost-effectiveness analysis to determine the cost-effectiveness of PSOT.
- 1 May 1998
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 35 (3) , 222-226
Short-term Cost-effectiveness Analysis of Presurgical Orthopedic Treatment in Children with Complete Unilateral Cleft Lip and Palate
Objective: The aim of this article was to investigate cost-effectiveness in cleft palate treatment using cost-effectiveness of presurgical orthopedic treatment (PSOT) as an example. Design: A three-center randomized clinical trial compared PSOT with non-PSOT for children with unilateral cleft lip and palate (UCLP, n=52). Patients: The inclusion criteria for the trial were: complete UCLP, no other malformations, born at term, both parents Caucasian, trial entrance preferably within 2 weeks after birth, and informed consent by the parents. Interventions: PSOT was performed by means of a passive plate according to Hotz and Gnoinski. Main Outcome Measure: The short-term cost-effectiveness of PSOT was based on the time taken for the surgical lip closure procedure. Medical and nonmedical costs until surgical lip closure at 18 weeks of age were analyzed. Results: The durations of the surgical lip closure procedures did not differ significantly (57.2 minutes for PSOT and 56.4 minutes for non-PSOT). The mean medical cost for PSOT treatment was US$852. The non-PSOT treatment group had a significantly different mean medical cost (US$304). Mean travel costs and indirect nonmedical costs were US$128 and US$231 for PSOT and US$79 and US$130 for non-PSOT, respectively. Conclusions: The combination of a clinical trial and an economic evaluation makes it possible to relate effects to costs involved in treatment alternatives. Longer-term costs and effects will be incorporated into an extended cost-effectiveness analysis to determine the cost-effectiveness of PSOT.